Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael D. Otremba, M.D.

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cranial Fossa, Anterior12013130.440 Why?
Prisons120151700.430 Why?
Hospital Charges120153590.430 Why?
Otitis12012200.410 Why?
Mastoiditis12012370.400 Why?
Agammaglobulinemia120121720.360 Why?
Maxilla120134900.340 Why?
Skull Base Neoplasms120132690.340 Why?
Antibodies, Monoclonal, Murine-Derived120126930.320 Why?
Immunoglobulins, Intravenous120126640.290 Why?
Poverty1201526950.220 Why?
Developing Countries1201528800.200 Why?
Parathyroid Glands120225180.180 Why?
Neoplasms, Unknown Primary120181020.140 Why?
Neck Dissection120182010.140 Why?
Papillomavirus Infections2201816000.130 Why?
Radiotherapy, Adjuvant2201817900.130 Why?
Thyroid Gland1202211690.130 Why?
Patient Credit and Collection12015160.130 Why?
Salivary Gland Neoplasms120183040.120 Why?
Head and Neck Neoplasms2201828800.110 Why?
Carcinoma, Squamous Cell2201840240.100 Why?
Human Rights120153060.100 Why?
Oropharyngeal Neoplasms120174910.100 Why?
Lymph Node Excision1201813050.100 Why?
Parotid Neoplasms120131570.100 Why?
Lymphatic Metastasis1201829450.090 Why?
Chemotherapy, Adjuvant1201835310.090 Why?
Neoplasm, Residual1201310080.070 Why?
SEER Program1201315320.070 Why?
Lymphoma1201318990.060 Why?
Immunologic Factors1201215890.050 Why?
Antirheumatic Agents1201213740.050 Why?
Kaplan-Meier Estimate3201865450.050 Why?
Parathyroidectomy120222410.040 Why?
Neoplasm Staging32018111410.040 Why?
Thyroidectomy120229030.030 Why?
Chronic Disease1201292830.030 Why?
Arthritis, Rheumatoid1201237630.030 Why?
Neoplasm Recurrence, Local1201392740.030 Why?
Drug Therapy120175040.030 Why?
Treatment Outcome32018649470.030 Why?
Humans920227602610.030 Why?
Prognosis32018296360.020 Why?
Survival Rate22018128060.020 Why?
Papillomaviridae1201711170.020 Why?
Proportional Hazards Models22018125320.020 Why?
Female620183910110.020 Why?
Propensity Score1201819180.020 Why?
Middle Aged520182201750.020 Why?
Follow-Up Studies12012392540.020 Why?
Tomography, X-Ray Computed12013204840.020 Why?
Young Adult22013586730.020 Why?
Retrospective Studies42018803010.020 Why?
Sex Distribution1201322950.020 Why?
Age Distribution1201328930.020 Why?
Male520183594130.020 Why?
Combined Modality Therapy1201885510.020 Why?
Magnetic Resonance Imaging12013362470.020 Why?
Survival Analysis12018101850.020 Why?
Aged420181689950.010 Why?
Disease-Free Survival1201368300.010 Why?
Incidence12013213780.010 Why?
Infant, Newborn12013261680.010 Why?
Infant12013360300.010 Why?
Child, Preschool12013420340.010 Why?
Aged, 80 and over12013589470.000 Why?
United States12013723630.000 Why?
Child12013797580.000 Why?
Adolescent12013877470.000 Why?
Adult120132198470.000 Why?
Otremba's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.